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Objectives: The goal of this retrospective cohort study was to investigate the multiple 
sclerosis-osteoarthritis relationship in adults followed in general practices in Germany. 
Methods: Patients aged 18-70 years who were diagnosed for the first time with multiple 
sclerosis in one of 1,193 general practices in Germany between 2005 and 2018 (index 
date) were included in this retrospective cohort study. Patients without multiple 
sclerosis were matched (1:1) to those with multiple sclerosis by sex, age, index year, 
general practice, obesity, injuries, and other types of arthritis (index date: a randomly 
selected visit date). The association between multiple sclerosis and the 10-year 
incidence of osteoarthritis was analyzed using Cox regression models. 
Results: There were 4,300 patients with multiple sclerosis and 4,300 patients without 
multiple sclerosis included in this study. The proportion of women was 69.3% and 
mean (SD) age was 43.6 (12.6) years. There was no significant association between 
multiple sclerosis and incident osteoarthritis in the overall sample (HR=0.95, 95% CI: 
0.83-1.09) as well as sex and age subgroups.  
Conclusions: Based on these findings, multiple sclerosis is not significantly associated 
with osteoarthritis. Further studies of longitudinal nature are warranted to corroborate 






Multiple sclerosis is a chronic and autoimmune disease of the central nervous system 
[1]. Approximatively 2.2 million people are affected by multiple sclerosis in the world 
[2]. Major advances have been made in the treatment of multiple sclerosis in the past 
decades [3], and these therapeutic advances have been associated with a significant 
decrease in the worldwide number of deaths (-11.5% between 1990 and 2016) [2]. In 
this context, long-term quality of life has become one of the most important aspects of 
the management of people with multiple sclerosis [4]. 
 
Several chronic physical conditions are known to negatively affect quality of life, and 
one of these conditions is osteoarthritis [5]. Osteoarthritis is a common disorder of the 
joints characterized by several pathological changes such as degradation of the 
articular cartilage, synovial inflammation and osteophyte formation [6]. The age-
standardized prevalence of osteoarthritis was 3,754 cases per 100,000 people in 2017, 
and the burden associated with this condition is estimated to increase in the next 
decades [7]. To date, no study has investigated the association between multiple 
sclerosis and osteoarthritis, although several factors may predispose people with 
multiple sclerosis to develop osteoarthritis. First, altered gait patterns are frequent in 
multiple sclerosis [8,9], and some joints of the lower extremity may be overused, 
potentially increasing the odds of cartilage degradation and osteoarthritis. Second, joint 
overuse may also involve the upper extremity in patients with severe multiple sclerosis 
who are using a manual wheelchair [10]. Third, multiple sclerosis is a risk factor for 
depression [11] and anxiety disorder [12], and these psychiatric conditions can lead to 
an increase in the incidence of osteoarthritis [13,14].  
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Therefore, the goal of this retrospective cohort study was to investigate the association 
between multiple sclerosis and osteoarthritis in a sample of 8,600 adults living in 
Germany. Given that osteoarthritis affects approximatively one out of five adults in 
Germany [15], research identifying risk factors for osteoarthritis in this country should 
be prioritized.  
 
Materials and methods 
 
Database 
Data from the Disease Analyzer database (IQVIA) were used for this study. This 
database contains demographic, clinical and therapeutical data anonymously collected 
from general and specialized practices from Germany [16]. In this country, general 
practices play a crucial role in patient referrals to specialized practices and in the 
overall management of these patients when specialized evaluation is done [17]. 
Clinical data were obtained with the International Classification of Diseases, 10th 
revision (ICD-10), while the European Pharmaceutical Market Research Association 
(EPhMRA) Anatomical Therapeutic Chemical Classification (ATC) system was used 
to compile therapeutical data. A number of criteria such as completeness of 
documentation or linkage between diagnoses and prescriptions were used to assess 
the quality of reported data. The sampling method for the Disease Analyzer database 
relies on statistics from all practices in Germany, and several strata (e.g., age of 
physician, community size category and region) are used to determine the panel 
composition of practices included in the database. Finally, it has previously been found 
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that the panel of practices included in the Disease Analyzer database is representative 
of general and specialized practices in Germany [16]. 
 
Study population 
This retrospective cohort study included patients who had received for the first time a 
confirmed diagnosis of multiple sclerosis (ICD-10: G35) in one of 1,193 general 
practices in Germany between January 2005 and December 2018 (index date). 
Inclusion criteria were as follows: observation time of at least 12 months prior to the 
index date; observation time of at least 12 months after the index date; age 18-70 years 
at the index date; and no osteoarthritis diagnosis (ICD-10: M15-M19) documented prior 
to the index date. After applying similar inclusion criteria, individuals without multiple 
sclerosis were matched (1:1) to those with multiple sclerosis by sex, age, index year, 
general practice, obesity (ICD-10: E66), injuries excluding head and thorax injuries 
(ICD-10: S00-S99 and T07 excluding S00-S09 and S20-S29), and other types of 
arthritis (ICD-10: M00-M14, M45-M49, M32, and L40.5). The index date was a 
randomly selected visit date for individuals without multiple sclerosis. The selection of 
study patients is displayed in Figure 1.  
 
Study variables 
Study variables included osteoarthritis (dependent variable), multiple sclerosis 
(independent variable), sex, age, obesity, injuries excluding head and thorax injuries, 
and other types of arthritis. Obesity, injuries and other types of arthritis were 
documented prior to the index date. All disorders included in this study corresponded 
to “confirmed diagnoses”, i.e., diagnoses most of the time confirmed by specialists or 




Baseline characteristics (i.e., sex, age, obesity, injuries excluding head and thorax 
injuries, and other types of arthritis) were compared between patients with multiple 
sclerosis and patients without multiple sclerosis using McNemar tests for all variables 
except continuous age (Wilcoxon signed-rank test). The distribution of the different 
types of osteoarthritis (i.e., polyosteoarthritis, hip osteoarthritis, knee osteoarthritis, 
first carpometacarpal joint osteoarthritis, and other and unspecified osteoarthritis) was 
further compared between the multiple sclerosis and the no multiple sclerosis group 
using a McNemar test. Finally, the association between multiple sclerosis and the 10-
year incidence of osteoarthritis was analyzed in the overall sample and in sex (i.e., 
female and male) and age subgroups (i.e., 18-30, 31-40, 41-50, 51-60, and 61-70 
years) using Cox regression models. Results from the Cox regression analyses are 
presented as hazard ratios (HRs) and 95% confidence intervals (CIs). P-values<0.05 




This retrospective cohort study included 4,300 patients with multiple sclerosis and 
4,300 patients without multiple sclerosis. There were 69.3% of women, and mean 
(standard deviation) age was 43.6 (12.6) years (Table 1). The prevalence of obesity, 
injuries excluding head and thorax injuries, and other types of arthritis was 7.0%, 
16.8%, and 10.2%, respectively. The distribution of the different types of osteoarthritis 
was not significantly different between the multiple sclerosis and the no multiple 
sclerosis group (p-value=0.130), and knee osteoarthritis was the most frequent type of 
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osteoarthritis in both groups (38%). The results of the Cox regression analyses are 
displayed in Table 2. There was no significant association between multiple sclerosis 
and the 10-year incidence of osteoarthritis in the overall sample (HR=0.95, 95% CI: 
0.83-1.09). Similar findings were obtained in sex (i.e., female and male) and age 





This retrospective cohort study including 8,600 adults from Germany revealed that the 
10-year incidence of osteoarthritis was around 16% in those with multiple sclerosis and 
around 17% in those without multiple sclerosis. The Cox regression analysis further 
showed that multiple sclerosis was not significantly associated with osteoarthritis in the 
overall population (HR = 0.95, 95% CI: 0.83-1.09). Similar findings were obtained in 
the sex and age subgroups. 
 
Interpretation of the findings  
To the best of the knowledge of the authors, this is the first study to have analyzed the 
potential relationship between multiple sclerosis and osteoarthritis. Interestingly, data 
on the association between multiple sclerosis and other types of arthritis are also 
relatively scarce. One nationwide cohort study of 11,818 patients found that the 
incidence of rheumatoid arthritis was significantly higher in those with than in those 
without multiple sclerosis (adjusted HR = 1.78) [18]. It was observed in another study, 
including 155 patients with multiple sclerosis and 200 controls, that rheumatoid 
arthritis, psoriasis and goitre were more frequent in the group with than in the group 
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without multiple sclerosis [19]. However, rheumatoid arthritis and osteoarthritis are two 
joint disorders with very different etiologies. Rheumatoid arthritis is an autoimmune 
condition affecting synovial joints [20], whereas osteoarthritis is an age-related disorder 
potentially affecting all types of joint and likely favored by mechanical stress and low-
grade inflammation [6]. Given that multiple sclerosis is also an autoimmune disease, it 
is not surprising that this neurological condition is associated with rheumatoid arthritis 
and not osteoarthritis. 
 
The lack of significant association between multiple sclerosis and osteoarthritis in this 
study conducted in Germany may be explained by several hypotheses. First, it is 
possible that multiple sclerosis indeed is not a risk factor for osteoarthritis. Although 
gait patterns are frequently altered [8,9] and the use of wheelchair is common in people 
with multiple sclerosis [10], levels of physical activity may not be sufficient enough to 
lead to cartilage destruction and to favor the occurrence of osteoarthritis. For example, 
a recent systematic review and meta-analysis including 32 studies revealed that the 
number of steps per day was significantly lower in individuals with than in those without 
multiple sclerosis (mean difference: -3,845) [21]. Second, a significant association may 
exist between multiple sclerosis and osteoarthritis for more severe forms of multiple 
sclerosis. Given that this study only included patients followed in general practices and, 
as patients with a more severe form of the disease are likely to be followed in 
specialized settings (e.g., neurological practices and hospital settings), this could 
explain the lack of significant results reported in the present study. Third, there may 
also be a relationship between multiple sclerosis and radiographic osteoarthritis and 
not clinical osteoarthritis. Unfortunately, the diagnosis of osteoarthritis relied on ICD-
10 codes and not on radiographic data. 
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Directions for future research 
The lack of significant association between multiple sclerosis and the 10-year 
incidence of osteoarthritis was the main finding of this study. Before drawing any 
conclusion, further research of longitudinal nature and conducted in other settings is 
needed to corroborate or invalidate the study results. In addition, more data on multiple 
sclerosis and osteoarthritis may allow to better understand the potential relationship 
between these two chronic conditions. 
 
Strengths and limitations 
The strengths of this study are the large sample size, the length of follow-up and the 
use of data obtained in general practices. However, these findings should be 
interpreted in the light of several limitations. First, there was a lack of data on the 
severity of multiple sclerosis, although a higher risk for osteoarthritis may exist in 
patients with severe multiple sclerosis only. Second, more information on osteoarthritis 
(e.g., clinical symptoms and radiographic abnormalities) would have allowed more 
detailed analyses. Third, this study included patients followed in general practices from 
Germany, and the findings may not be generalizable to other settings. Of note, most 
patients with multiple sclerosis are treated in neurological practices, although some 
symptomatic medications (e.g., nonsteroidal anti-inflammatory drugs) may be 
prescribed in general practices [22]. Fourth, patients who visited another practice could 
not be followed and were considered as lost to follow-up, potentially introducing a bias 
in the analyses. Fifth, multiple sclerosis is frequently misdiagnosed [23], and it is 
possible that the rate of misdiagnosis of multiple sclerosis was substantial in the 
present study. Sixth, although previous research has showed that the panel of 
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practices included in the Disease Analyzer database accurately represents primary 
care practices in Germany [16], it remains possible that the findings of this study may 
not be generalizable to the German general population.   
 
Conclusions  
Overall, there was no significant association between multiple sclerosis and 
osteoarthritis in this sample of 8,600 patients followed for up to 10 years in general 
practices in Germany. Before any conclusion is drawn, these results should be 




The authors have received no financial support for the research, authorship, and/or 
publication of this article. 
 
Conflict of interest 
The authors declare that they have no potential conflict of interest with respect to the 
research, authorship, and/or publication of this article. 
 
Ethical statement 
German law allows the use of anonymous electronic medical records for research 
purposes under certain conditions. According to this legislation, it is not necessary to 
obtain informed consent from patients or approval from a medical ethics committee for 
this type of observational study that contains no directly identifiable data. Finally, 
 11 
because patients were only queried as aggregates and no protected health information 
was available for queries, no IRB approval was required for the use of this database 





1  Dobson R, Giovannoni G. Multiple sclerosis - a review. Eur J Neurol. 2019 
Jan;26(1):27–40.  
2  Global, regional, and national burden of multiple sclerosis 1990–2016: a 
systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019 
Mar;18(3):269–85.  
3  Hauser SL, Cree BAC. Treatment of Multiple Sclerosis: A Review. Am J Med. 
2020 Dec;133(12):1380-1390.e2.  
4  Gil-González I, Martín-Rodríguez A, Conrad R, Pérez-San-Gregorio MÁ. 
Quality of life in adults with multiple sclerosis: a systematic review. BMJ Open. 2020 
Nov;10(11):e041249.  
5  Vitaloni M, Botto-van Bemden A, Sciortino Contreras RM, Scotton D, Bibas M, 
Quintero M, et al. Global management of patients with knee osteoarthritis begins with 
quality of life assessment: a systematic review. BMC Musculoskelet Disord. 2019 
Oct;20(1):493.  
6  Cucchiarini M, de Girolamo L, Filardo G, Oliveira JM, Orth P, Pape D, et al. 
Basic science of osteoarthritis. J Exp Orthop. 2016 Sep;3(1). DOI: 10.1186/s40634-
016-0060-6 
7  Safiri S, Kolahi A-A, Smith E, Hill C, Bettampadi D, Mansournia MA, et al. 
Global, regional and national burden of osteoarthritis 1990-2017: a systematic analysis 
of the Global Burden of Disease Study 2017. Ann Rheum Dis. 2020 Jun;79(6):819–
28.  
8  Kelleher KJ, Spence W, Solomonidis S, Apatsidis D. The characterisation of gait 
patterns of people with multiple sclerosis. Disabil Rehabil. 2010;32(15):1242–50.  
 13 
9  Dujmovic I, Radovanovic S, Martinovic V, Dackovic J, Maric G, Mesaros S, et 
al. Gait pattern in patients with different multiple sclerosis phenotypes. Mult Scler Relat 
Disord. 2017 Apr;13:13–20.  
10  Rankin JW, Kwarciak AM, Mark Richter W, Neptune RR. The influence of 
altering push force effectiveness on upper extremity demand during wheelchair 
propulsion. J Biomech. 2010 Oct;43(14):2771–9.  
11  Fornelos A, Espírito Santo V, Silva M, Roque M. Association between multiple 
sclerosis and depression. European Psychiatry. 2017 Apr;41:S632.  
12  Butler E, Matcham F, Chalder T. A systematic review of anxiety amongst people 
with Multiple Sclerosis. Mult Scler Relat Disord. 2016 Nov;10:145–68.  
13  Seavey WG, Kurata JH, Cohen RD. Risk factors for incident self-reported 
arthritis in a 20 year followup of the Alameda County Study Cohort. J Rheumatol. 2003 
Oct;30(10):2103–11.  
14  Aguilar-Gaxiola S, Loera G, Geraghty EM, Ton H, Lim CCW, de Jonge P, et al. 
Associations between DSM-IV mental disorders and subsequent onset of arthritis. J 
Psychosom Res. 2016 Mar;82:11–6.  
15  Fuchs J, Rabenberg M, Scheidt-Nave C. [Prevalence of selected 
musculoskeletal conditions in Germany: results of the German Health Interview and 
Examination Survey for Adults (DEGS1)]. Bundesgesundheitsblatt 
Gesundheitsforschung Gesundheitsschutz. 2013 May;56(5–6):678–86.  
16  Rathmann W, Bongaerts B, Carius H-J, Kruppert S, Kostev K. Basic 
characteristics and representativeness of the German Disease Analyzer database. Int 
J Clin Pharmacol Ther. 2018 Oct;56(10):459–66.  
17  Rosemann T, Wensing M, Rueter G, Szecsenyi J. Referrals from general 
practice to consultants in Germany: If the GP is the initiator, patients’ experiences are 
 14 
more positive. BMC Health Serv Res. 2006 Jan;6:5.  
18  Tseng C-C, Chang S-J, Tsai W-C, Ou T-T, Wu C-C, Sung W-Y, et al. Increased 
incidence of rheumatoid arthritis in multiple sclerosis: A nationwide cohort study. 
Medicine (Baltimore). 2016 Jun;95(26):e3999.  
19  Midgard R, Grønning M, Riise T, Kvåle G, Nyland H. Multiple sclerosis and 
chronic inflammatory diseases. A case-control study. Acta Neurol Scand. 1996 
May;93(5):322–8.  
20  Guo Q, Wang Y, Xu D, Nossent J, Pavlos NJ, Xu J. Rheumatoid arthritis: 
pathological mechanisms and modern pharmacologic therapies. Bone Res. 2018 
Apr;6. DOI: 10.1038/s41413-018-0016-9 
21  Casey B, Coote S, Galvin R, Donnelly A. Objective physical activity levels in 
people with multiple sclerosis: Meta-analysis. Scand J Med Sci Sports. 2018 
Sep;28(9):1960–9.  
22  Höer A, Schiffhorst G, Zimmermann A, Fischaleck J, Gehrmann L, Ahrens H, et 
al. Multiple sclerosis in Germany: data analysis of administrative prevalence and 
healthcare delivery in the statutory health system. BMC Health Serv Res. 2014 
Sep;14:381.  
23  Kaisey M, Solomon AJ, Luu M, Giesser BS, Sicotte NL. Incidence of multiple 
sclerosis misdiagnosis in referrals to two academic centers. Mult Scler Relat Disord. 





Baseline characteristics of study patients after 1:1 matching 
 







Female 2,980 (69.3) 2,980 (69.3) 1.000 
Male 1,320 (30.7) 1,320 (30.7) 
Age (in years) 
Age, mean (standard deviation) 43.6 (12.6) 43.6 (12.6) 1.000 
Age 18-30 789 (18.4) 789 (18.4) 
1.000 
Age 31-40 941 (21.9) 941 (21.9) 
Age 41-50 1,237 (28.8) 1,237 (28.8) 
Age 51-60 909 (21.1) 909 (21.1) 
Age 61-70 424 (9.8) 424 (9.8) 
Comorbidities documented prior to the index date 
Obesity 301 (7.0) 301 (7.0) 1.000 
Injuries excluding head and 
thorax injuries 
722 (16.8) 722 (16.8) 1.000 
Other types of arthritis 439 (10.2) 439 (10.2) 1.000 




Association between multiple sclerosis and the incidence of osteoarthritis in patients 











HR (95% CI) P-value 
Total 16.1 16.9 0.95 (0.83-1.09) 0.497 
Sex 
Female  16.5 17.3 1.00 (0.85-1.18) 0.992 
Male  15.2 15.7 0.85 (0.66-1.10) 0.212 
Age (in years) 
18-30 3.0 6.2 0.83 (0.43-1.62) 0.592 
31-40 8.5 9.7 0.86 (0.57-1.28) 0.450 
41-50 16.8 17.1 0.96 (0.76-1.23) 0.758 
51-60 23.4 28.7 0.89 (0.70-1.14) 0.364 
61-70 35.7 29.3 1.03 (0.75-1.39) 0.877 




Figure 1. Selection of study patients 
 
Figure 2. Distribution of the different types of osteoarthritis in patients with and without 
multiple sclerosis 
There was no significant difference in the distribution of the different types of osteoarthritis between the 
multiple sclerosis and the no multiple sclerosis group (p-value=0.130). 
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